0001127602-15-029507.txt : 20151023
0001127602-15-029507.hdr.sgml : 20151023
20151023175627
ACCESSION NUMBER: 0001127602-15-029507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151020
FILED AS OF DATE: 20151023
DATE AS OF CHANGE: 20151023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0328
BUSINESS ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fusco David
CENTRAL INDEX KEY: 0001649182
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 151173604
MAIL ADDRESS:
STREET 1: 400 WOOD RD
CITY: BRIANTREE
STATE: MA
ZIP: 02184
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-10-20
0000313143
HAEMONETICS CORP
HAE
0001649182
Fusco David
400 WOOD ROAD
BRAINTREE
MA
02184
1
EVP, Global Human Resources
Common Stock
2015-10-20
4
A
0
2736
.01
A
5415
D
Non-qualified Stock Option (Right to Buy)
31.97
2015-10-20
4
A
0
12030
31.97
A
2016-10-20
2022-10-20
Common Stock
12030
12030
D
Performance Shares
0
2015-10-20
4
A
0
5473
0
A
2018-09-30
2018-12-31
Common Stock
5473
5473
D
Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Performance Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Performance Share Unit based on the performance of Haemonetics stock price relative to the Standard & Poors Health Care Equipment Index. The number of Performance Share Units (and therefore the number of shares payable) will depend on the Company's stock price performance between October 1, 2015 and September 30, 2018. The Performance Share Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to twice the target amount in column 5. The Performance Share Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).
/s/ Alexander P. Steffan, attorney-in-fact for Mr. Fusco
2015-10-23